Alex Zisson's Net Worth
$4.89 Million
Who is Alex Zisson?
Alex Zisson has an estimated net worth of $4.89 Million. This is based on reported shares across multiple companies, which include Auspex Pharmaceuticals, Inc., Clarus Therapeutics Holdings, Inc., Ocera Therapeutics, Inc., and Celator Pharmaceuticals Inc.
SEC CIK
Alex Zisson's CIK is 0001512058
Past Insider Trading and Trends
2014 was Alex Zisson's most active year for acquiring shares with 10 total transactions. Alex Zisson's most active month to acquire stocks was the month of January. 2014 was Alex Zisson's most active year for disposing of shares, totalling 15 transactions. Alex Zisson's most active month to dispose stocks was the month of January. 2013 saw Alex Zisson paying a total of $29,631,426.00 for 4,938,571 shares, this is the most they've acquired in one year. In 2015 Alex Zisson cashed out on 5,908,874 shares for a total of $40,008,488.59, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Auspex Pharmaceuticals, Inc. No price found
InvestorAlex Zisson used to own units in Common Stock but no longer holds any shares there. In the year 2014 Alex Zisson acquired a total of 5,677,749 shares in Auspex Pharmaceuticals, Inc. at a cost of $2,982,037.36, Alex also disposed a total of 5,624,310 shares of Auspex Pharmaceuticals, Inc. equalling to $40,752,699.33.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -4.84M |
—
|
—
|
0
|
May 5
| |||
Form 4
| -13.12% | -730.00K |
$53.11 | -$38,770,300.00 | 4.84M |
Jan 28
| |||
Form 4
| +5.60% | 295.13K |
$27.73 | -$263.92 | 5.57M |
Jan 8
| |||
Form 4
| +0.97% | 50.38K |
$13.89 | -$54.61 | 5.27M |
Oct 9
| |||
Form 4/A
| +1.03% | 53.44K |
$12.24 | -$25.72 | 5.22M |
May 14
| |||
Form 4
| +1.03% | 53.44K |
$12.24 | -$25.72 | 5.22M |
May 14
| |||
Form 4
|
∞
| 5.17M |
$12.00 | $1,000,008.00 | 5.17M |
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Clarus Therapeutics Holdings, Inc. No price found
InvestorAlex Zisson owns 5,692,381 units of Common Stock. In the year 2021 Alex Zisson filed a total of 2 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 5.69M |
—
|
—
| 5.69M |
Sep 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ocera Therapeutics, Inc. No price found
InvestorAlex Zisson owns 8,986,358 units of Common Stock and 2,438,569 units of Common Stock, par value $0.00001 per share. From 2011 to 2013 Alex Zisson acquired a total of 7,940,857 shares in Ocera Therapeutics, Inc. at a cost of $32,881,426.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
∞
| 2.44M |
$6.00 | $14,631,414.00 | 2.44M |
Feb 6 - Jul 15
| |||
Form 4/A
|
∞
| 2.5M |
$6.00 | $15,000,012.00 | 2.5M |
Apr 19 - Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 19
| |||
Form 4
| +24.10% | 3M |
$4.00 | $3,250,000.00 | 15.46M |
Apr 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Celator Pharmaceuticals Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||